The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coming back to: Private prescribing in the UK: what is actually involved

This is a generated summary. It shows the 9 most-liked posts from a topic of 68, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
FL
f.laurentTL219 Dec 2025#2

My experience of Private prescribing contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.

26 likes 7mo
AI
a.ibarraTL226 Dec 2025#14

Post #12 and I disagree about the size of the effect, not about the direction.

What I want from this Private prescribing thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.

26 likes 7mo
VS
v.szaboTL3Analytical chemist28 Dec 2025#19

Adding the measurement that post #18 says would settle it.

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

I would want a second opinion before relying on that.

27 likes 7mo
P
PSkarbekTL3Regular31 Dec 2025#25

Sensible. I would want the same detail before I acted on it either.

22 likes 7mo
EC
excursion_checkTL3Regular1 Jan 2026#29

Where I part company with post #26, and it is a narrow parting.

Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so themselves.

30 likes 7mo
CE
crossover_entryTL3Regular2 Jan 2026#31

Private prescribing sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.

24 likes 7mo
NZ
n.zielinskiTL27 Jan 2026#46

Source for the Private prescribing figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.

Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.

27 likes 7mo
VT
vial_tableTL2Member11 Jan 2026#56
s.grahame, post #43: Cross-border movement between the two jurisdictions is not the same as domestic movement within either, and the rules are published rather than inferred. Go to post

Answering the question post #52 raises rather than the one it answers.

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

30 likes in reply to #43 7mo
JP
j.palaciosTL213 Jan 2026#64
b.frisk, post #51: Genuine question rather than a rhetorical one: has anyone here actually observed Private prescribing, as opposed to read about it? The thread is long and I cannot tell. Go to post

Building on post #61 rather than restating it.

A note on how Private prescribing gets discussed rather than on Private prescribing itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.

29 likes in reply to #51 6mo

Read the full topic (68 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
About the UK & Ireland category
MHRA positions, NHS pathways, private prescriptions, and Irish differences. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
SLHSJVIAK+3 7 357 3mo
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
DBDATFHKD+46 53 14k 12mo
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. Asking about pharmacy supply on behalf of the question I keep seeing asked…
CMCBRMNSP+95 105 1.3k 4mo
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
APSRNVEOVF+10 14 27k 2d
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Asking about MHRA statements directly, because I have read four threads on it and each…
BRTDSL 2 44k 22mo

Related topics — sharing the tags personal import, MHRA, NHS

TopicParticipantsRepliesViewsActivity
Second pass at: Cross-border purchase within the EU: the actual rules
Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. The question about Cross-border purchase within…
KVMSZILOWM+135 139 8.7k 16mo
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
APSRNVEOVF+10 14 27k 2d
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. Asking about MHRA statements directly, because I have read four threads on it and each…
VMSOGHTVJ+93 101 2.2k 5mo
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…
YISVCDAMB+70 74 7k 8mo
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. Asking what a regulator's document…
CRDPICCDJB+50 56 780 8mo